Salas Joanne, Scherrer Jeffrey F, Lustman Patrick J, Schneider F David
a Department of Family and Community Medicine , Saint Louis University School of Medicine , Saint Louis , Missouri , USA.
b Department of Psychiatry , Washington University School of Medicine , Saint Louis , Missouri , USA.
Subst Abus. 2016;37(1):25-30. doi: 10.1080/08897077.2015.1129523.
African Americans (AAs) have lower rates of depressive disorders and are less likely to receive opioid analgesics for chronic pain than whites. Given the evidence that prescription opioid use is associated with depression, we hypothesized that the opioid abuse/dependence and depression comorbidity would be less common among AAs compared with whites.
A cross-sectional secondary analysis of the public use files for the 2012 (n = 55,268) and 2013 (n = 55,160) National Survey on Drug Use and Health (NSDUH) was used to obtain past-year, DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) criteria diagnoses of nonmedical prescription opioid use (NMPOU), abuse/dependence, and major depressive episode (MDE). Covariates included anxiety disorder, alcohol and illicit drug abuse/dependence, smoking, age, gender, education, marital status, health insurance, county urbanicity, and income. Logistic regression models estimating the association between opioid use and MDE were computed before and after adjusting for covariates and separately for AAs and whites.
AAs and whites had similar past-year prevalence of NMPOU (3.5% vs. 3.7%) and abuse/dependence (0.7% vs. 0.9%). MDE was significantly more prevalent among whites (7.4% vs. 5.5%; P < .0001). Among whites, NMPOU and abuse/dependence were associated with MDE (odds ratio [OR] = 1.36, 95% confidence interval [CI] = 1.12-1.64 and OR = 2.22, 95% CI = 1.67-2.94, respectively). Among AAs, there were no significant associations between NMPOU, abuse/dependence, and MDE (OR range: 0.80-0.95).
In a nationally representative sample, co-occurrence of past-year depression, NMPOU, and abuse/dependence was determined in whites but not AAs. Additional research is needed to establish the contribution of pain and temporal relationships.
非裔美国人(AAs)患抑郁症的比率较低,且与白人相比,因慢性疼痛接受阿片类镇痛药治疗的可能性较小。鉴于有证据表明使用处方阿片类药物与抑郁症有关,我们推测与白人相比,阿片类药物滥用/依赖与抑郁症的共病情况在非裔美国人中不太常见。
对2012年(n = 55268)和2013年(n = 55160)全国药物使用和健康调查(NSDUH)的公开使用文件进行横断面二次分析,以获取过去一年中根据《精神疾病诊断与统计手册》第四版(DSM-IV)标准诊断的非医疗处方阿片类药物使用(NMPOU)、滥用/依赖和重度抑郁发作(MDE)情况。协变量包括焦虑症、酒精和非法药物滥用/依赖、吸烟、年龄、性别、教育程度、婚姻状况、医疗保险、县城市化程度和收入。在调整协变量之前和之后,分别针对非裔美国人和白人计算估计阿片类药物使用与MDE之间关联的逻辑回归模型。
非裔美国人和白人过去一年的NMPOU患病率(3.5%对3.7%)和滥用/依赖率(0.7%对0.9%)相似。白人中的MDE患病率显著更高(7.4%对5.5%;P <.0001)。在白人中,NMPOU和滥用/依赖与MDE相关(优势比[OR] = 1.36,95%置信区间[CI] = 1.12 - 1.64和OR = 2.22,95% CI = 1.67 - 2.94)。在非裔美国人中,NMPOU、滥用/依赖与MDE之间无显著关联(OR范围:0.80 - 0.95)。
在一个具有全国代表性的样本中,确定了白人中过去一年抑郁症、NMPOU和滥用/依赖的共病情况,但非裔美国人中未出现这种情况。需要进一步研究以确定疼痛和时间关系的作用。